Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Weight Loss Reduces Cancer Associated Protein Levels

A new study showed that overweight and obese women lowered levels of proteins associated with cancer after 1 year of calorie, fat reductions. [Rostislav_Sedlacek/Getty Images] A new study by researchers at the Fred Hutchinson Cancer Research Center (Hutch) in

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

A new study showed that overweight and obese women lowered levels of proteins associated with cancer after 1 year of calorie, fat reductions. [Rostislav_Sedlacek/Getty Images]

A new study by researchers at the Fred Hutchinson Cancer Research Center (Hutch) in Seattle describes how overweight and obese women who significantly lowered their weight through diet and exercise reduced the levels of certain proteins in their blood that play a role in angiogenesis, the process of blood vessel growth that has been intimately associated with the proliferation and survival of cancer cells.

“We know that being overweight and having a sedentary lifestyle is associated with an increase in risk for developing certain types of cancer. However, we don't know exactly why,” explained lead study author Catherine Duggan, Ph.D., principal staff scientist in the public health sciences division at the Hutch. “We wanted to investigate how levels of some biomarkers associated with angiogenesis were altered when overweight, sedentary, postmenopausal women enrolled in a research study lost weight and/or became physically active over the course of a year.”

Interestingly, the research also showed that similar-sized women who exercised regularly, but maintained their usual calorie intake, did not post big drops in pounds or in those suspect proteins—adding to the growing knowledge of information that points to the importance of diet and exercise to maintain proper weight and overall good health. “The fact that exercise alone had little effect was surprising,” Dr. Duggan remarked.

“Many people still think they just need to exercise a little more, and they’ll lose a lot of weight. Doesn’t happen,” noted senior study author Anne McTiernan, M.D., Ph.D., a cancer prevention researcher at the Hutch.

The findings from this study were published recently in Cancer Research in an article entitled “Dietary Weight Loss and Exercise Effects on Serum Biomarkers of Angiogenesis in Overweight Postmenopausal Women: A Randomized Controlled Trial.”

The study was broken up into four arms: a caloric restriction diet arm in which women restricted their calorie intake to no more than 2000 kcal per day that included less than 30% of fat calories; an aerobic exercise arm in which women performed 45 minutes of moderate to vigorous exercise 5 days a week; and a combined diet + exercise arm; and a control arm (no intervention). The study investigators randomly assigned 439 overweight/obese, healthy, sedentary, postmenopausal women, aged 50 to 75, to one of the four study arms to measure the effect of exercise and diet on the circulating levels of proteins related to angiogenesis after 12 months.

Blood samples were collected at baseline and at 12 months. In each of those samples, researchers measured three proteins—vascular endothelial growth factor (VEGF), plasminogen activator inhibitor type 1 (PAI-1), and pigment epithelium-derived factor (PEDF)—that flow through the body and help in the formation of new blood vessels, a process called angiogenesis.

Angiogenesis is a vital function where new blood vessels are formed, for example, during wound healing. Unfortunately, an important part of tumor growth and development is also dependent on having a supply of blood vessels to deliver nutrients and oxygen to allow a tumor to continue to grow. The three measured proteins have been shown previously to be involved in nurturing the growth and survival of cancer cells.

The research team found that women who adhered for 1 year to the caloric restriction and lower-fat eating—or a combination of the diet and workout plans—had significantly decreased levels of the angiogenesis-related proteins.

“Our study shows that weight loss is a safe and effective method of improving the angiogenic profile in healthy individuals. We were surprised by the magnitude of change in these biomarkers with weight loss,” Dr. Duggan said.

Dr. Duggan continued, stating that “while we can't say for certain that reducing the circulating levels of angiogenic factors through weight loss would impact the growth of tumors, it is possible that they might be associated with a less favorable milieu for tumor growth and proliferation.”

The findings do add to a growing body of evidence showing the link between being overweight and having elevated levels of certain proteins associated with a higher cancer risk. Moreover, the authors suggest that they would advise sedentary, overweight, older adults to perhaps use the findings as a motivation to improve their diets and add more cardio.

“Exercise is important for helping to prevent weight gain, and to maintain weight loss, but does not cause a large amount of weight loss on its own,” Dr. Duggan noted. “Our study shows that making lifestyle changes—in this case, simple changes to the diet to reduce weight—can lower the risk factors for cancer.”

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Undruggable or unscreenable?

Another obstacle to discovering new PPI inhibitors is the lack of libraries designed to hunt for them, points out Philippe Roche, PhD, senior scientist at the Integrative Structural and Chemical Biology team at the Cancer Research Center of Marseilles, France. “If you screen PPIs using libraries that were designed for kinases or GPCRs, that’s why you don’t get a lot of good results,” he says. To that end, his group began assembling a library focused on orthosteric inhibitors of PPIs. The result was 2P2Idb, a hand-curated, structural database cataloguing orthosteric inhibitors of PPIs for which the interface had been 3D characterized. From analyzing these known PPI inhibitors, and what structures they had in common, Roche and his colleagues developed a model to predict whether compounds would likely inhibit PPIs. Using this method, 2P2Idb creates an enriched screening library that dramatically increases the hit rate compared to standard libraries. Having proven their success with a small library of 1600 compounds, they are in the process of expanding the library to 10,000 compounds. Once that’s published, “the idea is to make this library available to labs around the world,” Roche says. “We will provide the library free of charge for people to be able to screen PPI targets.”

Source: www.genengnews.com ↗
02How stable is the antibody?

A crucial question often addressed during preclinical development focuses on the in vivo stability of therapeutic antibodies. Increasing the half-life of a therapeutic antibody has several benefits ranging from higher treatment efficacy to increased advantages for the patients who will have a fewer number of therapy sessions and a reduced cost. Given these compelling benefits, following the identification of therapeutic antibodies with the desired specificity, developers usually subject them to a refinement step to increase their stability. This process is often hindered by the lack of reliable experimental tools to predict the half-life of antibodies in patients. The major hurdle of using mouse models to predict antibody stability in the serum lies in the way immunoglobulin proteins are processed by the organism. In mammals, most proteins circulating in the serum undergo constant uptake by endothelial cells and are routed through the endosomes to the lysosomal compartment for degradation. In the endosomes, immunoglobulin G (IgG) proteins are recognized and bound by a transmembrane protein, called the neonatal Fc receptor (FcRn), which mediates their recycling to the plasma membrane and subsequent release back into the serum. As a result, the half-life of IgGs are significantly extended by this mechanism. Since most therapeutic antibodies belong to the IgG class, this recycling system is very relevant for their relative stability in the body. Remarkably, the relative affinity between IgGs and FcRn is extremely disparate between different species, with the mouse receptor showing a much higher affinity than its human counterpart.

Source: www.genengnews.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →